Back to results
US 2006/0189654 A1Published application
Novel compounds
AssigneeTheravance, Inc.
InventorLois Vernon
Life of this patent
Estimating the term…
Abstract
This invention relates to cinnamate salts of 5-[(R)-2-(2-{4-[4-(2-amino-2-methyl-propoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one.
Claims18
A salt of the compound of formula (I):
- wherein said salt is selected from the group consisting of cinnamate, 4-methoxycinnamate, di-(4-phenylcinnamate) and 4-methyl cinnamate salt.
A crystalline form of the salt of 5-[(R)-2-(2-{4-[4-(2-amino-2-methyl-propoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one, wherein the crystalline salt is selected from the group consisting of cinnamate, 4-methoxycinnamate, di-(4-phenylcinnamate) and 4-methyl cinnamate salt.
Dependencies are inferred from the claim text.